Sumitomo Mitsui DS Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.1M Buy
54,015
+137
+0.3% +$65.8K 0.19% 101
2026
Q1
$26.5M Buy
53,878
+745
+1% +$404K 0.21% 92
2025
Q4
$30.8M Buy
53,133
+1,560
+3% +$882K 0.24% 79
2025
Q3
$25M Buy
51,573
+478
+0.9% +$222K 0.2% 94
2025
Q2
$20.7M Sell
51,095
-6,234
-11% -$2.61M 0.19% 101
2025
Q1
$28.5M Buy
57,329
+1,741
+3% +$943K 0.29% 68
2024
Q4
$28.9M Buy
55,588
+1,213
+2% +$667K 0.3% 68
2024
Q3
$33.6M Buy
54,375
+2,264
+4% +$1.34M 0.36% 58
2024
Q2
$28.8M Buy
52,111
+1,308
+3% +$749K 0.34% 62
2024
Q1
$29.5M Sell
50,803
-622
-1% -$349K 0.37% 60
2023
Q4
$27.3M Buy
51,425
+662
+1% +$320K 0.36% 60
2023
Q3
$25.7M Sell
50,763
-868
-2% -$463K 0.4% 55
2023
Q2
$26.9M Buy
51,631
+10,123
+24% +$5.46M 0.41% 55
2023
Q1
$23.9M Buy
41,508
+1,477
+4% +$832K 0.43% 55
2022
Q4
$22M Buy
40,031
+1,652
+4% +$875K 0.45% 55
2022
Q3
$19.5M Buy
38,379
+1,390
+4% +$778K 0.44% 50
2022
Q2
$20.1M Buy
36,989
+1,053
+3% +$580K 0.48% 49
2022
Q1
$21.2M Buy
35,936
+176
+0.5% +$101K 0.45% 51
2021
Q4
$23.9M Buy
35,760
+876
+3% +$547K 0.5% 42
2021
Q3
$19.9M Sell
34,884
-394
-1% -$216K 0.47% 48
2021
Q2
$17.8M Sell
35,278
-8,041
-19% -$3.79M 0.42% 54
2021
Q1
$19.8M Buy
43,319
+3,159
+8% +$1.51M 0.52% 45
2020
Q4
$18.7M Buy
40,160
+2,419
+6% +$1.13M 0.53% 43
2020
Q3
$16.7M Buy
37,741
+678
+2% +$280K 0.53% 44
2020
Q2
$13.4M Sell
37,063
-993
-3% -$333K 0.46% 51
2020
Q1
$10.8M Buy
38,056
+1,105
+3% +$348K 0.44% 51
2019
Q4
$12M Sell
36,951
-1,121
-3% -$340K 0.41% 53
2019
Q3
$11.1M Buy
38,072
+3,869
+11% +$1.11M 0.41% 53
2019
Q2
$10M Sell
34,203
-486
-1% -$134K 0.41% 53
2019
Q1
$9.49M Buy
34,689
+178
+0.5% +$44.3K 0.16% 131
2018
Q4
$7.72M Sell
34,511
-920
-3% -$216K 0.14% 142
2018
Q3
$8.65M Sell
35,431
-254
-0.7% -$58.4K 0.13% 139
2018
Q2
$7.39M Buy
35,685
+422
+1% +$89.6K 0.11% 147
2018
Q1
$7.28M Sell
35,263
-1,783
-5% -$374K 0.11% 151
2017
Q4
$7.03M Sell
37,046
-2,205
-6% -$422K 0.11% 161
2017
Q3
$7.43M Sell
39,251
-2,964
-7% -$537K 0.12% 163
2017
Q2
$7.37M Sell
42,215
-4,954
-11% -$832K 0.12% 161
2017
Q1
$7.25M Sell
47,169
-911
-2% -$139K 0.12% 167
2016
Q4
$6.78M Sell
48,080
-304
-0.6% -$44.8K 0.13% 168
2016
Q3
$7.7M Sell
48,384
-3,312
-6% -$510K 0.17% 157
2016
Q2
$7.64M Sell
51,696
-6,882
-12% -$1.02M 0.23% 119
2016
Q1
$8.29M Buy
58,578
+2,645
+5% +$354K 0.26% 116
2015
Q4
$7.93M Sell
55,933
-21,166
-27% -$2.82M 0.27% 113
2015
Q3
$9.43M Sell
77,099
-7,451
-9% -$971K 0.32% 101
2015
Q2
$11M Sell
84,550
-4,015
-5% -$523K 0.35% 82
2015
Q1
$11.9M Sell
88,565
-5,036
-5% -$649K 0.36% 78
2014
Q4
$11.7M Sell
93,601
-6,379
-6% -$776K 0.36% 78
2014
Q3
$12.2M Buy
99,980
+7,101
+8% +$863K 0.37% 78
2014
Q2
$11M Sell
92,879
-16,727
-15% -$1.97M 0.31% 91
2014
Q1
$13.2M Sell
109,606
-3,343
-3% -$397K 0.39% 64
2013
Q4
$12.6M Buy
112,949
+28,005
+33% +$2.78M 0.36% 69
2013
Q3
$7.83M Buy
84,944
+37,454
+79% +$3.39M 0.22% 106
2013
Q2
$4.02M Buy
+47,490
New +$3.95M 0.11% 176

Other funds holding TMO

Sumitomo Mitsui DS Asset Management's TMO Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Thermo Fisher Scientific (TMO) stake by 0.25% in Q2 2026, buying an estimated $65.8K and bringing the position to 54,015 shares worth $27.1M. The position accounts for 0.19% of the portfolio, ranked #101.

Sumitomo Mitsui DS Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.6M in Q3 2024. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 54,015 shares of Thermo Fisher Scientific worth $27.1M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 137 Thermo Fisher Scientific shares in Q2 2026, an estimated $65.8K.
  • Thermo Fisher Scientific made up 0.19% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #101 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui DS Asset Management's Thermo Fisher Scientific position peaked at $33.6M in Q3 2024.
  • 2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.